Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome

被引：3
|
作者：
Vatopoulou, Anastasia [1 ]
Dionelli, Maria-Eleni [2 ]
Papanikolaou, Alexis [1 ]
Grover, Sonia [3 ]
机构：
[1] Aristotle Univ Thessaloniki, AHEPA Hosp, Med Sch, Dept Obstet & Gynecol 2, Thessaloniki 55133, Greece
[2] Abertay Univ, Sch Biomed Sci, Dundee, Scotland
[3] Royal Childrens Hosp, Dept Pediat & Adolescent Gynecol, Melbourne, Vic, Australia
来源：
CURRENT PHARMACEUTICAL DESIGN | 2021年 / 27卷 / 36期
关键词：
Polycystic ovary syndrome; adolescence; obesity; type 2 diabetes mellitus; hyperandrogenemia; anovulation; METABOLIC SYNDROME; INSULIN-RESISTANCE; OBESE ADOLESCENTS; NONOBESE ADOLESCENTS; GLUCOSE-TOLERANCE; ASSOCIATION; PREVALENCE; HYPERANDROGENISM; ABNORMALITIES; ADIPONECTIN;
D O I：
10.2174/1381612826666201127123357
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
It is well-established that adults with polycystic ovary syndrome (PCOS) have an increased preva-lence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present review summa-rizes the existing evidence regarding the prevalence of traditional and non-traditional cardiometabolic risk fac-tors in adolescents with PCOS.
引用
收藏
页码：3808 / 3811
页数：4
相关论文
共 50 条
  • [1] Cardiometabolic risk factors in polycystic ovary syndrome
    Mehrabian, Ferdous
    Keramatian, Kasra
    Kelishadi, Roya
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (02) : 339 - 344
  • [2] Cardiometabolic risk in polycystic ovary syndrome
    Studen, Katica Bajuk
    Pfeifer, Marija
    [J]. ENDOCRINE CONNECTIONS, 2018, 7 (07): : R238 - +
  • [3] Cardiometabolic risk in patients with polycystic ovary syndrome
    Ozegowska, Katarzyna
    Pawelczyk, Leszek
    [J]. GINEKOLOGIA POLSKA, 2015, 86 (11) : 840 - 848
  • [4] Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (09): : 1045 - 1052
  • [5] The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome
    Krysiak, Robert
    Kowalcze, Karolina
    Okopien, Boguslaw
    [J]. PHARMACOLOGY, 2023, 108 (05) : 451 - 459
  • [6] The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Robert Krysiak
    Witold Szkróbka
    Bogusław Okopień
    [J]. Pharmacological Reports, 2021, 73 : 261 - 268
  • [7] The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
    Krysiak, Robert
    Szkrobka, Witold
    Okopien, Boguslaw
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 261 - 268
  • [8] Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Paterakis, Thomas S.
    Diamanti-Kandarakis, Evanthia
    [J]. CURRENT OBESITY REPORTS, 2014, 3 (04): : 377 - 386
  • [9] Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
    Cinar, Nese
    Kizilarslanoglu, Muhammed Cemal
    Harmanci, Ayla
    Aksoy, Duygu Yazgan
    Bozdag, Gurkan
    Demir, Basaran
    Yildiz, Bulent Okan
    [J]. HUMAN REPRODUCTION, 2011, 26 (12) : 3339 - 3345
  • [10] Cardiometabolic Risk in Polycystic Ovary Syndrome Current Guidelines
    Cooney, Laura G.
    Dokras, Anuja
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2021, 50 (01) : 83 - 95
12345